نتایج جستجو برای: flt3 itd

تعداد نتایج: 4119  

آتش‌رزم, فرزانه, ذاکر, فرهاد, علی مقدم, کامران, پاژخ, وحید,

  چکید ه   سابقه و هدف   NPM1 / نوکلئوفسمین/ B23 ، یک فسفوپروتئین با میزان بیان بالا در سلول‌های در حال تکثیر است. بیماران AML با NPM1 به شکل شایعی دارای جهش‌های FLT3 ITD می‌باشند. هدف این تحقیق بررسی میزان فراوانی جهش‌های NPM1 و FLT3 ITD در بیماران AML ایرانی و ارتباط این جهش‌ها با زیر گروه‌های AML در طبقه‌بندی FAB بود.   مواد و روش‌ها   مطالعه انجام شده از نوع توصیفی مقطعی بود. نمونه‌های مغز ...

Journal: :Oncotarget 2015
Elisa Zuffa Eugenia Franchini Cristina Papayannidis Carmen Baldazzi Giorgia Simonetti Nicoletta Testoni Maria Chiara Abbenante Stefania Paolini Chiara Sartor Sarah Parisi Giovanni Marconi Federica Cattina Maria Teresa Bochicchio Claudia Venturi Emanuela Ottaviani Michele Cavo Giovanni Martinelli

FLT3 internal tandem duplication (ITD), one of the most frequent mutations in Acute Myeloid Leukemia (AML), is reported to be an unstable marker, as it can evolve from FLT3 ITD- to ITD+ during the disease course. A single-gene sensitive mutational screening approach may be helpful for better clarifying the exact timing of mutation occurrence, especially when FLT3 ITD appears to occur late, at d...

Journal: :Blood 2013
Marta Pratcorona Salut Brunet Josep Nomdedéu Josep Maria Ribera Mar Tormo Rafael Duarte Lourdes Escoda Ramon Guàrdia M Paz Queipo de Llano Olga Salamero Joan Bargay Carmen Pedro Josep Maria Martí Montserrat Torrebadell Marina Díaz-Beyá Mireia Camós Dolors Colomer Montserrat Hoyos Jorge Sierra Jordi Esteve

Risk associated to FLT3 internal tandem duplication (FLT3-ITD) in patients with acute myeloid leukemia (AML) may depend on mutational burden and its interaction with other mutations. We analyzed the effect of FLT3-ITD/FLT3 wild-type (FLT3wt) ratio depending on NPM1 mutation (NPM1mut) in 303 patients with intermediate-risk cytogenetics AML treated with intensive chemotherapy. Among NPM1mut patie...

2008
Soo-Mee Bang Jeong Yeal Ahn Jiyoon Park Se Hoon Park Jinny Park Eun Kyung Cho Dong Bok Shin Jae Hoon Lee Soo Jin Yoo In Sang Jeon Yeo-Kyeoung Kim Hyeoung Joon Kim Hee-Nam Kim Il-Kwon Lee Hyoung Jin Kang Hee Young Shin Hyo Seop Ahn

FLT3 mutations are common genetic changes, and are reported to have prognostic significance in acute myeloid leukemia (AML). The FLT3 internal tandem duplication (ITD) and the D835 activating mutation in the tyrosine kinase domain (TKD) were analyzed by polymerase chain reaction (PCR) in the genomic DNA of Korean patients with AML at diagnosis and during follow-up. There were 226 patients with ...

Journal: :iranian biomedical journal 0
مرجان یغمایی marjan yaghmaie کامران علی مقدم kamran alimoghaddam حسین مزدرانی hossein mozdarani اردشیر قوام زاده ardeshir ghavamzadeh مرجان حاج قاسمی marjan hajhashemi مظفر ازنب mozaffar aznab سید حمداله غفاری

background: the secondary genetic changes other than the promyelocytic leukemia-retinoic acid receptor (pml-rara) fusion gene may contribute to the acute promyelocytic leukemogenesis. chromosomal alterations and mutation of flt3 (fms-like tyrosine kinase 3) tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia. however, the prognostic significance of flt3 mutat...

جوادی, غلامرضا, ذاکر, فرهاد, رزم خواه, فرناز, شیخی, مریم, هاشمی, مهرداد,

سابقه و هدف: جهش ژن flt3 (گیرنده تیروزین کینازی شبه) FMS باعث تکثیر بدون کنترل سلول های لوسمیک شده و پیش آگهی بدی را به همراه دارد. هدف ما از این مطالعه اجرایی کردن آزمایشات مولکولی برای تشخیص و غربالگری این جهش ها در مبتلایان لوسمی های حاد بود.روش بررسی: در این مطالعه بنیادی، 91 کودک مبتلا به لوسمی های حاد میلوئیدی (AML) و لنفوئیدی (ALL) از نظر جهش در ژن flt3 شامل وجود جهش ITD (Internal Tandem...

Journal: :Blood 2012
Allen B Williams Li Li Bao Nguyen Patrick Brown Mark Levis Donald Small

FLT3 is frequently mutated in acute myeloid leukemia (AML), but resistance has limited the benefit of tyrosine kinase inhibitors (TKI). We demonstrate that statins can impair FLT3 glycosylation, thus leading to loss of surface expression and induction of cell death, as well as mitigation of TKI resistance. Immunofluorescence microscopy confirms a reduction in surface localization and an increas...

Journal: :International journal of clinical and experimental medicine 2015
Gaixiang Xu Liping Mao Hui Liu Min Yang Jie Jin Wenbin Qian

The presence of internal tandem duplications (ITD) in the Fms-related tyrosine kinase 3 receptor (FLT3) has been associated with a poor prognosis in acute myeloid leukemia (AML). Over the past decade, FLT3 is a promising target in FLT3-ITD-positive AML. Sorafenib which is one of the commonly focused FLT3 inhibitors may improve outcome, but only few patients display long-term responses in previo...

Journal: :Croatian medical journal 2008
Hong-Ling Peng Guang-Sen Zhang Fan-Jie Gong Jian-Kai Shen Yang Zhang Yun-Xiao Xu Wen-Li Zheng Chong-Wen Dai Min-Fei Pei Jun-Jie Yang

AIM To assess the expression level of fms-like tyrosine kinase 3 (FLT3), the incidence of FLT3/internal tandem duplications (ITD) mutation, and prognostic value of FLT3 changes in different types of adult leukemia. METHODS Bone marrow mononuclear cells were isolated from 147 adult patients with leukemia. Reverse transcriptase polymerase chain reaction (PCR) was used to screen FLT3/ITD mutatio...

2016
Pankit Vachhani Jason H Mendler Andrew Evans George Deeb Petr Starostik Paul K Wallace Eunice S Wang

Spontaneous remission (SR) of acute myeloid leukemia (AML) is a very rare phenomenon. AML characterized by FLT3 internal tandem duplication (FLT3 ITD) is typically associated with an aggressive clinical course with rapid progression, relapse, and short overall survival in the absence of transplantation. We report here the first case of SR of FLT3 ITD mutant AML in the literature. Our patient wa...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید